Shopping Cart 0
Cart Subtotal
USD 0

Global Autologous Cell Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 4880

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 7320

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 9760

Details

Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is to reduce the chance of rejecting treatment in the body. In addition, autologous cell therapy does not require immunosuppression.

Scope of the Report:

The global Autologous Cell Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Autologous Cell Therapy.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Autologous Cell Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Autologous Cell Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers

BioTime

Pharmicell

BrainStorm Cell Therapeutics

Opexa Therapeutics

Vericel Corporation

Regeneus

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Bone Marrow

Epidermis

Market Segment by Applications, can be divided into

Neurology

Orthopedics

Cancer

Wound Healing

Other

READ MORE

Table Of Content

Scope

Table of Contents

1 Autologous Cell Therapy Market Overview

1.1 Product Overview and Scope of Autologous Cell Therapy

1.2 Classification of Autologous Cell Therapy by Types

1.2.1 Global Autologous Cell Therapy Revenue Comparison by Types (2019-2024)

1.2.2 Global Autologous Cell Therapy Revenue Market Share by Types in 2018

1.2.3 Bone Marrow

1.2.4 Epidermis

1.3 Global Autologous Cell Therapy Market by Application

1.3.1 Global Autologous Cell Therapy Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Neurology

1.3.3 Orthopedics

1.3.4 Cancer

1.3.5 Wound Healing

1.3.6 Other

1.4 Global Autologous Cell Therapy Market by Regions

1.4.1 Global Autologous Cell Therapy Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Autologous Cell Therapy Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Autologous Cell Therapy Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Autologous Cell Therapy Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Autologous Cell Therapy Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Autologous Cell Therapy Status and Prospect (2014-2024)

1.5 Global Market Size of Autologous Cell Therapy (2014-2024)

2 Company Profiles

2.1 BioTime

2.1.1 Business Overview

2.1.2 Autologous Cell Therapy Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 BioTime Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.2 Pharmicell

2.2.1 Business Overview

2.2.2 Autologous Cell Therapy Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Pharmicell Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.3 BrainStorm Cell Therapeutics

2.3.1 Business Overview

2.3.2 Autologous Cell Therapy Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.4 Opexa Therapeutics

2.4.1 Business Overview

2.4.2 Autologous Cell Therapy Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Opexa Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.5 Vericel Corporation

2.5.1 Business Overview

2.5.2 Autologous Cell Therapy Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Vericel Corporation Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.6 Regeneus

2.6.1 Business Overview

2.6.2 Autologous Cell Therapy Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Regeneus Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

3 Global Autologous Cell Therapy Market Competition, by Players

3.1 Global Autologous Cell Therapy Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Autologous Cell Therapy Players Market Share

3.2.2 Top 10 Autologous Cell Therapy Players Market Share

3.3 Market Competition Trend

4 Global Autologous Cell Therapy Market Size by Regions

4.1 Global Autologous Cell Therapy Revenue and Market Share by Regions

4.2 North America Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

4.3 Europe Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

4.5 South America Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

5 North America Autologous Cell Therapy Revenue by Countries

5.1 North America Autologous Cell Therapy Revenue by Countries (2014-2019)

5.2 USA Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

5.3 Canada Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

5.4 Mexico Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

6 Europe Autologous Cell Therapy Revenue by Countries

6.1 Europe Autologous Cell Therapy Revenue by Countries (2014-2019)

6.2 Germany Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

6.3 UK Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

6.4 France Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

6.5 Russia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

6.6 Italy Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Autologous Cell Therapy Revenue by Countries

7.1 Asia-Pacific Autologous Cell Therapy Revenue by Countries (2014-2019)

7.2 China Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

7.3 Japan Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

7.4 Korea Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

7.5 India Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

8 South America Autologous Cell Therapy Revenue by Countries

8.1 South America Autologous Cell Therapy Revenue by Countries (2014-2019)

8.2 Brazil Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

8.3 Argentina Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

8.4 Colombia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Autologous Cell Therapy by Countries

9.1 Middle East and Africa Autologous Cell Therapy Revenue by Countries (2014-2019)

9.2 Saudi Arabia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

9.3 UAE Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

9.4 Egypt Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

9.5 Nigeria Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

9.6 South Africa Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

10 Global Autologous Cell Therapy Market Segment by Type

10.1 Global Autologous Cell Therapy Revenue and Market Share by Type (2014-2019)

10.2 Global Autologous Cell Therapy Market Forecast by Type (2019-2024)

10.3 Bone Marrow Revenue Growth Rate (2014-2024)

10.4 Epidermis Revenue Growth Rate (2014-2024)

11 Global Autologous Cell Therapy Market Segment by Application

11.1 Global Autologous Cell Therapy Revenue Market Share by Application (2014-2019)

11.2 Autologous Cell Therapy Market Forecast by Application (2019-2024)

11.3 Neurology Revenue Growth (2014-2019)

11.4 Orthopedics Revenue Growth (2014-2019)

11.5 Cancer Revenue Growth (2014-2019)

11.6 Wound Healing Revenue Growth (2014-2019)

11.7 Other Revenue Growth (2014-2019)

12 Global Autologous Cell Therapy Market Size Forecast (2019-2024)

12.1 Global Autologous Cell Therapy Market Size Forecast (2019-2024)

12.2 Global Autologous Cell Therapy Market Forecast by Regions (2019-2024)

12.3 North America Autologous Cell Therapy Revenue Market Forecast (2019-2024)

12.4 Europe Autologous Cell Therapy Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Autologous Cell Therapy Revenue Market Forecast (2019-2024)

12.6 South America Autologous Cell Therapy Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Autologous Cell Therapy Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Autologous Cell Therapy Picture

Table Product Specifications of Autologous Cell Therapy

Table Global Autologous Cell Therapy and Revenue (Million USD) Market Split by Product Type

Figure Global Autologous Cell Therapy Revenue Market Share by Types in 2018

Figure Bone Marrow Picture

Figure Epidermis Picture

Table Global Autologous Cell Therapy Revenue (Million USD) by Application (2014-2024)

Figure Autologous Cell Therapy Revenue Market Share by Applications in 2018

Figure Neurology Picture

Figure Orthopedics Picture

Figure Cancer Picture

Figure Wound Healing Picture

Figure Other Picture

Table Global Market Autologous Cell Therapy Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Autologous Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Autologous Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Autologous Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Autologous Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Autologous Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Autologous Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Table BioTime Basic Information, Manufacturing Base and Competitors

Table BioTime Autologous Cell Therapy Type and Applications

Table BioTime Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Pharmicell Basic Information, Manufacturing Base and Competitors

Table Pharmicell Autologous Cell Therapy Type and Applications

Table Pharmicell Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table BrainStorm Cell Therapeutics Basic Information, Manufacturing Base and Competitors

Table BrainStorm Cell Therapeutics Autologous Cell Therapy Type and Applications

Table BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Opexa Therapeutics Basic Information, Manufacturing Base and Competitors

Table Opexa Therapeutics Autologous Cell Therapy Type and Applications

Table Opexa Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Vericel Corporation Basic Information, Manufacturing Base and Competitors

Table Vericel Corporation Autologous Cell Therapy Type and Applications

Table Vericel Corporation Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Regeneus Basic Information, Manufacturing Base and Competitors

Table Regeneus Autologous Cell Therapy Type and Applications

Table Regeneus Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Global Autologous Cell Therapy Revenue (Million USD) by Players (2014-2019)

Table Global Autologous Cell Therapy Revenue Share by Players (2014-2019)

Figure Global Autologous Cell Therapy Revenue Share by Players in 2017

Figure Global Autologous Cell Therapy Revenue Share by Players in 2018

Figure Global Top 5 Players Autologous Cell Therapy Revenue Market Share in 2018

Figure Global Top 10 Players Autologous Cell Therapy Revenue Market Share in 2018

Figure Global Autologous Cell Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Autologous Cell Therapy Revenue (Million USD) by Regions (2014-2019)

Table Global Autologous Cell Therapy Revenue Market Share by Regions (2014-2019)

Figure Global Autologous Cell Therapy Revenue Market Share by Regions (2014-2019)

Figure Global Autologous Cell Therapy Revenue Market Share by Regions in 2018

Figure North America Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Europe Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure South America Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Table North America Autologous Cell Therapy Revenue by Countries (2014-2019)

Table North America Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure North America Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure North America Autologous Cell Therapy Revenue Market Share by Countries in 2018

Figure USA Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Canada Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Mexico Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Table Europe Autologous Cell Therapy Revenue (Million USD) by Countries (2014-2019)

Figure Europe Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure Europe Autologous Cell Therapy Revenue Market Share by Countries in 2018

Figure Germany Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure UK Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure France Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Russia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Italy Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Autologous Cell Therapy Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Autologous Cell Therapy Revenue Market Share by Countries in 2018

Figure China Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Japan Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Korea Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure India Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Table South America Autologous Cell Therapy Revenue by Countries (2014-2019)

Table South America Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure South America Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure South America Autologous Cell Therapy Revenue Market Share by Countries in 2018

Figure Brazil Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Argentina Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Colombia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Autologous Cell Therapy Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Autologous Cell Therapy Revenue Market Share by Countries in 2018

Figure Saudi Arabia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure UAE Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Egypt Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Nigeria Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure South Africa Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Table Global Autologous Cell Therapy Revenue (Million USD) by Type (2014-2019)

Table Global Autologous Cell Therapy Revenue Share by Type (2014-2019)

Figure Global Autologous Cell Therapy Revenue Share by Type (2014-2019)

Figure Global Autologous Cell Therapy Revenue Share by Type in 2018

Table Global Autologous Cell Therapy Revenue Forecast by Type (2019-2024)

Figure Global Autologous Cell Therapy Market Share Forecast by Type (2019-2024)

Figure Global Bone Marrow Revenue Growth Rate (2014-2019)

Figure Global Epidermis Revenue Growth Rate (2014-2019)

Table Global Autologous Cell Therapy Revenue by Application (2014-2019)

Table Global Autologous Cell Therapy Revenue Share by Application (2014-2019)

Figure Global Autologous Cell Therapy Revenue Share by Application (2014-2019)

Figure Global Autologous Cell Therapy Revenue Share by Application in 2018

Table Global Autologous Cell Therapy Revenue Forecast by Application (2019-2024)

Figure Global Autologous Cell Therapy Market Share Forecast by Application (2019-2024)

Figure Global Neurology Revenue Growth Rate (2014-2019)

Figure Global Orthopedics Revenue Growth Rate (2014-2019)

Figure Global Cancer Revenue Growth Rate (2014-2019)

Figure Global Wound Healing Revenue Growth Rate (2014-2019)

Figure Global Other Revenue Growth Rate (2014-2019)

Figure Global Autologous Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Autologous Cell Therapy Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Autologous Cell Therapy Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Autologous Cell Therapy Revenue Market Forecast (2019-2024)

Figure Europe Autologous Cell Therapy Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Autologous Cell Therapy Revenue Market Forecast (2019-2024)

Figure South America Autologous Cell Therapy Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Autologous Cell Therapy Revenue Market Forecast (2019-2024)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

BioTime

Pharmicell

BrainStorm Cell Therapeutics

Opexa Therapeutics

Vericel Corporation

Regeneus

Company Profile

Company Profile Title

Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is to reduce the chance of rejecting treatment in the body. In addition, autologous cell therapy does not require immunosuppression.

Scope of the Report:

The global Autologous Cell Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Autologous Cell Therapy.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Autologous Cell Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Autologous Cell Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers

BioTime

Pharmicell

BrainStorm Cell Therapeutics

Opexa Therapeutics

Vericel Corporation

Regeneus

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Bone Marrow

Epidermis

Market Segment by Applications, can be divided into

Neurology

Orthopedics

Cancer

Wound Healing

Other

READ MORE

Scope

Table of Contents

1 Autologous Cell Therapy Market Overview

1.1 Product Overview and Scope of Autologous Cell Therapy

1.2 Classification of Autologous Cell Therapy by Types

1.2.1 Global Autologous Cell Therapy Revenue Comparison by Types (2019-2024)

1.2.2 Global Autologous Cell Therapy Revenue Market Share by Types in 2018

1.2.3 Bone Marrow

1.2.4 Epidermis

1.3 Global Autologous Cell Therapy Market by Application

1.3.1 Global Autologous Cell Therapy Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Neurology

1.3.3 Orthopedics

1.3.4 Cancer

1.3.5 Wound Healing

1.3.6 Other

1.4 Global Autologous Cell Therapy Market by Regions

1.4.1 Global Autologous Cell Therapy Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Autologous Cell Therapy Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Autologous Cell Therapy Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Autologous Cell Therapy Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Autologous Cell Therapy Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Autologous Cell Therapy Status and Prospect (2014-2024)

1.5 Global Market Size of Autologous Cell Therapy (2014-2024)

2 Company Profiles

2.1 BioTime

2.1.1 Business Overview

2.1.2 Autologous Cell Therapy Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 BioTime Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.2 Pharmicell

2.2.1 Business Overview

2.2.2 Autologous Cell Therapy Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Pharmicell Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.3 BrainStorm Cell Therapeutics

2.3.1 Business Overview

2.3.2 Autologous Cell Therapy Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.4 Opexa Therapeutics

2.4.1 Business Overview

2.4.2 Autologous Cell Therapy Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Opexa Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.5 Vericel Corporation

2.5.1 Business Overview

2.5.2 Autologous Cell Therapy Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Vericel Corporation Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

2.6 Regeneus

2.6.1 Business Overview

2.6.2 Autologous Cell Therapy Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Regeneus Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

3 Global Autologous Cell Therapy Market Competition, by Players

3.1 Global Autologous Cell Therapy Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Autologous Cell Therapy Players Market Share

3.2.2 Top 10 Autologous Cell Therapy Players Market Share

3.3 Market Competition Trend

4 Global Autologous Cell Therapy Market Size by Regions

4.1 Global Autologous Cell Therapy Revenue and Market Share by Regions

4.2 North America Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

4.3 Europe Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

4.5 South America Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

5 North America Autologous Cell Therapy Revenue by Countries

5.1 North America Autologous Cell Therapy Revenue by Countries (2014-2019)

5.2 USA Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

5.3 Canada Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

5.4 Mexico Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

6 Europe Autologous Cell Therapy Revenue by Countries

6.1 Europe Autologous Cell Therapy Revenue by Countries (2014-2019)

6.2 Germany Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

6.3 UK Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

6.4 France Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

6.5 Russia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

6.6 Italy Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Autologous Cell Therapy Revenue by Countries

7.1 Asia-Pacific Autologous Cell Therapy Revenue by Countries (2014-2019)

7.2 China Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

7.3 Japan Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

7.4 Korea Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

7.5 India Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

8 South America Autologous Cell Therapy Revenue by Countries

8.1 South America Autologous Cell Therapy Revenue by Countries (2014-2019)

8.2 Brazil Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

8.3 Argentina Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

8.4 Colombia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Autologous Cell Therapy by Countries

9.1 Middle East and Africa Autologous Cell Therapy Revenue by Countries (2014-2019)

9.2 Saudi Arabia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

9.3 UAE Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

9.4 Egypt Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

9.5 Nigeria Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

9.6 South Africa Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

10 Global Autologous Cell Therapy Market Segment by Type

10.1 Global Autologous Cell Therapy Revenue and Market Share by Type (2014-2019)

10.2 Global Autologous Cell Therapy Market Forecast by Type (2019-2024)

10.3 Bone Marrow Revenue Growth Rate (2014-2024)

10.4 Epidermis Revenue Growth Rate (2014-2024)

11 Global Autologous Cell Therapy Market Segment by Application

11.1 Global Autologous Cell Therapy Revenue Market Share by Application (2014-2019)

11.2 Autologous Cell Therapy Market Forecast by Application (2019-2024)

11.3 Neurology Revenue Growth (2014-2019)

11.4 Orthopedics Revenue Growth (2014-2019)

11.5 Cancer Revenue Growth (2014-2019)

11.6 Wound Healing Revenue Growth (2014-2019)

11.7 Other Revenue Growth (2014-2019)

12 Global Autologous Cell Therapy Market Size Forecast (2019-2024)

12.1 Global Autologous Cell Therapy Market Size Forecast (2019-2024)

12.2 Global Autologous Cell Therapy Market Forecast by Regions (2019-2024)

12.3 North America Autologous Cell Therapy Revenue Market Forecast (2019-2024)

12.4 Europe Autologous Cell Therapy Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Autologous Cell Therapy Revenue Market Forecast (2019-2024)

12.6 South America Autologous Cell Therapy Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Autologous Cell Therapy Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Autologous Cell Therapy Picture

Table Product Specifications of Autologous Cell Therapy

Table Global Autologous Cell Therapy and Revenue (Million USD) Market Split by Product Type

Figure Global Autologous Cell Therapy Revenue Market Share by Types in 2018

Figure Bone Marrow Picture

Figure Epidermis Picture

Table Global Autologous Cell Therapy Revenue (Million USD) by Application (2014-2024)

Figure Autologous Cell Therapy Revenue Market Share by Applications in 2018

Figure Neurology Picture

Figure Orthopedics Picture

Figure Cancer Picture

Figure Wound Healing Picture

Figure Other Picture

Table Global Market Autologous Cell Therapy Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Autologous Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Autologous Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Autologous Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Autologous Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Autologous Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Autologous Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)

Table BioTime Basic Information, Manufacturing Base and Competitors

Table BioTime Autologous Cell Therapy Type and Applications

Table BioTime Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Pharmicell Basic Information, Manufacturing Base and Competitors

Table Pharmicell Autologous Cell Therapy Type and Applications

Table Pharmicell Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table BrainStorm Cell Therapeutics Basic Information, Manufacturing Base and Competitors

Table BrainStorm Cell Therapeutics Autologous Cell Therapy Type and Applications

Table BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Opexa Therapeutics Basic Information, Manufacturing Base and Competitors

Table Opexa Therapeutics Autologous Cell Therapy Type and Applications

Table Opexa Therapeutics Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Vericel Corporation Basic Information, Manufacturing Base and Competitors

Table Vericel Corporation Autologous Cell Therapy Type and Applications

Table Vericel Corporation Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Regeneus Basic Information, Manufacturing Base and Competitors

Table Regeneus Autologous Cell Therapy Type and Applications

Table Regeneus Autologous Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)

Table Global Autologous Cell Therapy Revenue (Million USD) by Players (2014-2019)

Table Global Autologous Cell Therapy Revenue Share by Players (2014-2019)

Figure Global Autologous Cell Therapy Revenue Share by Players in 2017

Figure Global Autologous Cell Therapy Revenue Share by Players in 2018

Figure Global Top 5 Players Autologous Cell Therapy Revenue Market Share in 2018

Figure Global Top 10 Players Autologous Cell Therapy Revenue Market Share in 2018

Figure Global Autologous Cell Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Autologous Cell Therapy Revenue (Million USD) by Regions (2014-2019)

Table Global Autologous Cell Therapy Revenue Market Share by Regions (2014-2019)

Figure Global Autologous Cell Therapy Revenue Market Share by Regions (2014-2019)

Figure Global Autologous Cell Therapy Revenue Market Share by Regions in 2018

Figure North America Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Europe Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure South America Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Table North America Autologous Cell Therapy Revenue by Countries (2014-2019)

Table North America Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure North America Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure North America Autologous Cell Therapy Revenue Market Share by Countries in 2018

Figure USA Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Canada Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Mexico Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Table Europe Autologous Cell Therapy Revenue (Million USD) by Countries (2014-2019)

Figure Europe Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure Europe Autologous Cell Therapy Revenue Market Share by Countries in 2018

Figure Germany Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure UK Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure France Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Russia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Italy Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Autologous Cell Therapy Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Autologous Cell Therapy Revenue Market Share by Countries in 2018

Figure China Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Japan Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Korea Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure India Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Table South America Autologous Cell Therapy Revenue by Countries (2014-2019)

Table South America Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure South America Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure South America Autologous Cell Therapy Revenue Market Share by Countries in 2018

Figure Brazil Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Argentina Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Colombia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Autologous Cell Therapy Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Autologous Cell Therapy Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Autologous Cell Therapy Revenue Market Share by Countries in 2018

Figure Saudi Arabia Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure UAE Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Egypt Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure Nigeria Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Figure South Africa Autologous Cell Therapy Revenue and Growth Rate (2014-2019)

Table Global Autologous Cell Therapy Revenue (Million USD) by Type (2014-2019)

Table Global Autologous Cell Therapy Revenue Share by Type (2014-2019)

Figure Global Autologous Cell Therapy Revenue Share by Type (2014-2019)

Figure Global Autologous Cell Therapy Revenue Share by Type in 2018

Table Global Autologous Cell Therapy Revenue Forecast by Type (2019-2024)

Figure Global Autologous Cell Therapy Market Share Forecast by Type (2019-2024)

Figure Global Bone Marrow Revenue Growth Rate (2014-2019)

Figure Global Epidermis Revenue Growth Rate (2014-2019)

Table Global Autologous Cell Therapy Revenue by Application (2014-2019)

Table Global Autologous Cell Therapy Revenue Share by Application (2014-2019)

Figure Global Autologous Cell Therapy Revenue Share by Application (2014-2019)

Figure Global Autologous Cell Therapy Revenue Share by Application in 2018

Table Global Autologous Cell Therapy Revenue Forecast by Application (2019-2024)

Figure Global Autologous Cell Therapy Market Share Forecast by Application (2019-2024)

Figure Global Neurology Revenue Growth Rate (2014-2019)

Figure Global Orthopedics Revenue Growth Rate (2014-2019)

Figure Global Cancer Revenue Growth Rate (2014-2019)

Figure Global Wound Healing Revenue Growth Rate (2014-2019)

Figure Global Other Revenue Growth Rate (2014-2019)

Figure Global Autologous Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Autologous Cell Therapy Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Autologous Cell Therapy Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Autologous Cell Therapy Revenue Market Forecast (2019-2024)

Figure Europe Autologous Cell Therapy Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Autologous Cell Therapy Revenue Market Forecast (2019-2024)

Figure South America Autologous Cell Therapy Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Autologous Cell Therapy Revenue Market Forecast (2019-2024)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

BioTime

Pharmicell

BrainStorm Cell Therapeutics

Opexa Therapeutics

Vericel Corporation

Regeneus